APP and pancreatic neoplasm: A recent study reported APLP2 C-terminal fragment and APLP2-modified glycosaminoglycan are highly expressed in pancreatic cancer cell lines (S2-013, BxPC3) as compared with APP full-length and C-terminal fragments [49].